Fig. 1From: DNA methylation in peripheral blood leukocytes for the association with glucose metabolism and invasive breast cancerDiagram of EWA and BC study populations from the WHI and TCGA cohorts. BC Breast cancer, CpGs CpG dinucleotide, DNAm DNA methylation, ER/PR + Estrogen receptor/progesterone receptor–positive, EWA Epigenome-wide association, HER2/neu– Human epidermal growth factor receptor-2–negative; TCGA The Cancer Genomic Atlas, WHI Women’s Health Initiative. * Individuals within Stage 2 had DNAm data measured at 2 visits and, for the analysis, the DNAm of those with a shorter interval between enrollment and blood draw were selected. ** Those selection criteria were applied to TCGA BC tissues. § The cases of HER2/neu– contained 49 (13% of BC cases) triple negativesBack to article page